Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Jun. 30, 2024
Assets:    
Cash and cash equivalents $ 12,061 $ 24,447
Accounts receivable, net of allowance of $473 and $294 as of September 30, 2024 and June 30, 2024, respectively 3,832 3,911
Inventory 3,168 2,223
Investment tax credits receivable 3,197 3,197
Other current assets 3,449 2,991
Total current assets 25,707 36,769
Property and equipment, net 12,372 12,905
Goodwill 6,508 6,508
Intangibles, net 11,910 12,565
Operating lease right-of-use asset, net 803 923
Other assets 71 71
Total Assets 57,371 69,741
Current Liabilities:    
Accounts payable and accrued expenses 15,303 16,352
Litigation related contingent liability 57,738 57,372
Notes payable 6,219 10,000
Deferred revenue 301 131
Operating lease liability 525 514
Total current liabilities 80,086 84,369
Long-term Liabilities:    
Convertible notes payable, net 42,054 41,887
Operating lease liability 329 462
Other long-term liabilities 117 117
Total long-term liabilities 42,500 42,466
Total Liabilities 122,586 126,835
Commitments and Contingencies (Note 14)
Stockholders’ Equity (Deficit)    
Preferred stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 175,000,000 shares authorized; 154,590,918, and 123,392,181 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively 154 123
Additional paid in capital 379,557 381,289
Accumulated deficit (444,926) (438,506)
Total Stockholders’ Equity (Deficit) (65,215) (57,094)
Total Liabilities and Stockholders’ Equity (Deficit) $ 57,371 $ 69,741